Northwell Study Shows Promising Seizure Reduction for Chronic Epilepsy Patients
Northwell Study Offers Nuanced Hope for Long-Term Seizure Reduction in Chronic, Treatment-Resistant Epilepsy For millions of individuals worldwide, epilepsy remains one of the most challenging chronic neurological disorders to manage.…
Ondex Automation Buys PlantOPS Consulting to Boost Life Sciences
ONDEX Automation Acquires PlantOPS Consulting, Expands MES and Life Sciences Capabilities ONDEX Automation has announced the acquisition of PlantOPS Consulting, a well-established specialist in Manufacturing Execution System (MES) consulting and…
Mirum Pharmaceuticals Announces Q3 2025 Financial Results and Business Highlights
Mirum Pharmaceuticals Announces Third Quarter 2025 Results and Highlights Strong Commercial Execution, Pipeline Advancement, and Strategic Positioning for 2026–2027 Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company dedicated to transforming…
Stoke Therapeutics Announces Q3 2025 Results & Business Update
Stoke Therapeutics Reports Third Quarter 2025 Results and Highlights Clinical and Corporate Progress Toward Transformational RNA Medicines Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering the use of RNA-based…
Catalent Showcases SMARTag® ADC Pipeline at World ADC San Diego
Catalent Showcases SMARTag® ADC Pipeline Progress and New Enhanced Conjugate Class at 16th World ADC San Diego Catalent, Inc., a global leader in contract development and manufacturing services for advanced…
BioSpace Honors enGene as a 2026 Best Place to Work
enGene Honored by BioSpace as a 2026 Best Place to Work, Underscoring Strong Culture and Mission-Driven Innovation enGene Holdings Inc. (“enGene” or the “Company”) (Nasdaq: ENGN), a clinical-stage, non-viral genetic…
QIAGEN Buys Parse Biosciences to Expand Single-Cell Tools
QIAGEN to Acquire Parse Biosciences, Expanding Portfolio into Scalable Single-Cell Sequencing and AI-Driven Discovery QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced that it has entered into a definitive agreement…
NMDP to Showcase New Research Driving Improved Transplant Access and Cell Therapy Innovation at ASH 2025
NMDP and CIBMTR to Present Research Advancing Transplant Access and Cell Therapy Innovation at ASH 2025 NMDP℠, a leading global nonprofit dedicated to advancing cell therapy, and the CIBMTR® (Center…
PharmaJet to Present Intradermal Program Results at ASTMH Meeting
PharmaJet to Showcase Advancements in Intradermal Needle-Free Delivery at ASTMH Annual Meeting PharmaJet®, a leading company focused on transforming injectable delivery through needle-free technology, announced that it will present new…
Zetagen to Share Phase 2 Data on Bone-Metastatic Breast Cancer at SABCS 2025
Zetagen Therapeutics Announces Presentation of Promising Phase 2a Data Demonstrating Complete Responses in Metastatic Breast Cancer Bone Lesions at 2025 SABCS Zetagen Therapeutics, a privately held clinical-stage biopharmaceutical company developing…
Serenity Mental Health Launches Ketamine Treatment in Colorado Springs
Serenity Mental Health Centers Expands Access to Breakthrough Ketamine Treatment in Colorado Springs Serenity Mental Health Centers, one of the nation’s fastest-growing providers of advanced psychiatric care, has announced the…
Zoetis Names Kevin Esch as New R&D President, Succeeding Rob Polzer in 2026
Zoetis Appoints Kevin Esch as New R&D President to Succeed Rob Polzer in 2026, Marking a Strategic Leadership Transition in Global Animal Health Innovation Zoetis Inc. (NYSE: ZTS), the world’s…